Table 1 Demographic and clinical characteristics of patients (N = 105)
Characteristic | Category | n (%) |
|---|---|---|
Sex | Male | 90 (85.7) |
Female | 15 (14.3) | |
Age (years) |  < 45 | 43 (41.0) |
 ≥ 45 | 62 (59.0) | |
HBsAg | Negative | 12 (11.4) |
Positive | 93 (88.6) | |
HBV-DNA (IU/mL) |  < 5.0 × 102 | 30 (28.6) |
 ≥ 5.0 × 102 | 75 (71.4) | |
AFP (ng/mL) |  < 400 | 46 (43.8) |
 ≥ 400 | 59 (56.2) | |
Tumor size (cm) |  < 5 | 23 (21.9) |
 ≥ 5 | 82 (78.1) | |
Tumor number | Single | 65 (61.9) |
Multiple | 40 (38.1) | |
Edmondson grade | I–II | 63 (60.0) |
III–IV | 42 (40.0) | |
Tumor capsule | Incomplete | 41 (39.0) |
Complete | 64 (61.0) | |
MVI | Negative | 33 (31.4) |
Positive | 72 (68.6) | |
PVTT | Negative | 82 (78.1) |
Positive | 23 (21.9) | |
Liver cirrhosis | Negative | 4 (3.8) |
Positive | 101 (96.2) | |
BCLC stage | 0-A | 57 (54.3) |
B-C | 48 (45.7) | |
VCE | Negative | 41 (39.0) |
Positive | 64 (61.0) |